{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T11:25:44Z","timestamp":1698233144220},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1988,6,1]],"date-time":"1988-06-01T00:00:00Z","timestamp":581126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1988,6]]},"DOI":"10.1007\/bf00405835","type":"journal-article","created":{"date-parts":[[2004,10,24]],"date-time":"2004-10-24T11:56:13Z","timestamp":1098618973000},"page":"283-290","source":"Crossref","is-referenced-by-count":25,"title":["Immunotherapy of hepatocellular carcinoma with autologous lymphokine-activated killer cells and\/or recombinant interleukin-2"],"prefix":"10.1007","volume":"114","author":[{"given":"Takashi","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imawari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumimaro","family":"Takaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"2124","volume":"50","author":"JJ Alexander","year":"1976","unstructured":"Alexander JJ, Bey EM, Geddes EM, Lecatsas G (1976) Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50:2124?2128","journal-title":"S Afr Med J"},{"key":"CR2","first-page":"561","volume":"3","author":"AE Chang","year":"1984","unstructured":"Chang AE, Hyatt CL, Rosenberg SA (1984) Systemic administration of recombinant human interleukin-2 in mice. J Biol Response Mod 3:561?572","journal-title":"J Biol Response Mod"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4049\/jimmunol.130.5.2203","volume":"130","author":"JH Donohue","year":"1983","unstructured":"Donohue JH, Rosenberg SA (1983) The fate of interleukin-2 after in vivo administration. J Immunol 130:2203?2208","journal-title":"J Immunol"},{"key":"CR4","first-page":"2784","volume":"46","author":"SE Ettinghausen","year":"1986","unstructured":"Ettinghausen SE, Rosenberg SA (1986) Immunotherapy of murine sarcemas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. Cancer Res 46:2784?2792","journal-title":"Cancer Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grinm","year":"1982","unstructured":"Grinm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous blood lymphocytes. J Exp Med 155:1823?1841","journal-title":"J Exp Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.4049\/jimmunol.136.10.3910","volume":"136","author":"K Itoh","year":"1986","unstructured":"Itoh K, Tilden AB, Balch CM (1986) Lysis of human solid tumor cells by lymphokine-activated natural killer cells. J Immunol 136:3910?3915","journal-title":"J Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3171\/jns.1986.64.5.0743","volume":"64","author":"SK Jacobs","year":"1986","unstructured":"Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA (1986) Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. A preliminary report. J Neurosurg 64:743?749","journal-title":"J Neurosurg"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0065-230X(08)60190-6","volume":"38","author":"E Kedar","year":"1983","unstructured":"Kedar E, Weiss DW (1983) The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy. Adv Cancer Res 38:171?287","journal-title":"Adv Cancer Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.135.6.4273","volume":"135","author":"R Lafreniere","year":"1985","unstructured":"Lafreniere R, Rosenberg SA (1985) Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J Immunol 135:4273?4280","journal-title":"J Immunol"},{"key":"CR10","first-page":"4420","volume":"41","author":"MT Lotze","year":"1981","unstructured":"Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41:4420?4425","journal-title":"Cancer Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4049\/jimmunol.135.4.2865","volume":"135","author":"MT Lotze","year":"1985","unstructured":"Lotze MT, Matory YL, Ettinghausen SE, Rayner AA, Sharrow SO, Seipp CAY, Custer MC, Rosenberg SA (1985) In vivo administration of purified human interleukin 2. II. Half life and immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J Immunol 135:2865?2875","journal-title":"J Immunol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(19840215)53:4<896::AID-CNCR2820530414>3.0.CO;2-E","volume":"53","author":"A Mazumder","year":"1984","unstructured":"Mazumder A, Eberlein TJ, Grimm EA, Wilson DJ, Keenan AM, Aamodt R (1984) Phase I study of the adoptive immunotherapy of human cancer with lectin-activated autologous mononuclear cells. Cancer 53:896?905","journal-title":"Cancer"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.6332379","volume":"225","author":"JJ Mule","year":"1984","unstructured":"Mule JJ, Shu S, Schwarz SL, Rosenberg SA (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225:1487?1479","journal-title":"Science"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4049\/jimmunol.135.1.646","volume":"135","author":"JJ Mule","year":"1985","unstructured":"Mule JJ, Shu S, Rosenberg SA (1985) The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo. J Immunol 135:646?652","journal-title":"J Immunol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1097-0142(19850315)55:6<1327::AID-CNCR2820550628>3.0.CO;2-O","volume":"55","author":"AA Rayner","year":"1985","unstructured":"Rayner AA, Grimm EA, Lotze MT, Chu EW, Rosenberg SA (1985) Lymphokine-activated killer (LAK) cells: analysis of factors relevant to the immunotherapy of human cancer. Cancer 55:1327?1333","journal-title":"Cancer"},{"key":"CR16","first-page":"233","volume":"68","author":"SA Rosenberg","year":"1984","unstructured":"Rosenberg SA (1984a) Adoptive immunotherapy of cancer: accomplishment and prospects. Cancer Treat Rep 68:233?255","journal-title":"Cancer Treat Rep"},{"key":"CR17","first-page":"501","volume":"3","author":"SA Rosenberg","year":"1984","unstructured":"Rosenberg SA (1984b) Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2. J Biol Response Mod 3:501?511","journal-title":"J Biol Response Mod"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"SA Rosenberg","year":"1985","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485?1492","journal-title":"N Engl J Med"},{"key":"CR19","first-page":"581","volume":"130","author":"E Watkins Jr","year":"1970","unstructured":"Watkins E Jr, Khazei AM, Khalil SN (1970) Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 130:581?605","journal-title":"Surg Gynecol Obstet"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00405835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00405835\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00405835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T17:43:44Z","timestamp":1682790224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00405835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988,6]]}},"alternative-id":["BF00405835"],"URL":"https:\/\/doi.org\/10.1007\/bf00405835","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,6]]}}}